4/15
08:00 am
amrn
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
Medium
Report
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
4/15
07:27 am
amrn
Metastatic Liver Cancer Pipeline Insight 2024, Featuring Key Players Oncorus, Sirnaomics, Codiak BioSciences, RemeGen, Amarin, Medivir, AstraZeneca, Amal Therapeutics and Boehringer Ingelheim [Yahoo! Finance]
Medium
Report
Metastatic Liver Cancer Pipeline Insight 2024, Featuring Key Players Oncorus, Sirnaomics, Codiak BioSciences, RemeGen, Amarin, Medivir, AstraZeneca, Amal Therapeutics and Boehringer Ingelheim [Yahoo! Finance]
4/8
08:00 am
amrn
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
Neutral
Report
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
4/6
03:34 pm
amrn
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups [Yahoo! Finance]
Medium
Report
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups [Yahoo! Finance]
4/6
03:30 pm
amrn
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
Medium
Report
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
4/4
02:43 pm
amrn
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe [Yahoo! Finance]
Medium
Report
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe [Yahoo! Finance]
4/3
08:24 am
amrn
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe [Yahoo! Finance]
Medium
Report
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe [Yahoo! Finance]
4/3
08:00 am
amrn
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
Medium
Report
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
3/25
08:06 am
amrn
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo [Yahoo! Finance]
Low
Report
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo [Yahoo! Finance]
3/25
08:00 am
amrn
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
Low
Report
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
3/1
11:10 am
amrn
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
Low
Report
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
3/1
08:58 am
amrn
Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/29
03:40 pm
amrn
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/29
07:55 am
amrn
Amarin Corp PLC (AMRN) Faces Revenue Decline Amidst Generic Competition [Yahoo! Finance]
High
Report
Amarin Corp PLC (AMRN) Faces Revenue Decline Amidst Generic Competition [Yahoo! Finance]
2/29
07:23 am
amrn
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
2/29
07:00 am
amrn
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
High
Report
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2/15
08:00 am
amrn
Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024
Low
Report
Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024
1/22
07:45 am
amrn
Amarin Chairman & CEO Issue Letter to Shareholders [Yahoo! Finance]
Medium
Report
Amarin Chairman & CEO Issue Letter to Shareholders [Yahoo! Finance]
1/22
07:30 am
amrn
Amarin Chairman & CEO Issue Letter to Shareholders
Medium
Report
Amarin Chairman & CEO Issue Letter to Shareholders